Update your browser

This page does not support your version of browser.
Please update your IE version.

Browser Update


An open-label, Phase I, dose-escalation study evaluating the safety and tolerability of GDC-0853 in patients with relapsed or refractory B-cell non-Hodgkins lymphoma and chronic lymphocytic leukemia protocol number: GO29089

A pragmatic equivalence randomized controlled trial to investigate the effectiveness of ultrasound guided Ethanol Ablation and Radiofrequency Ablation for the treatment of chronic Morton’s Neuroma.
This is a randomised controlled trial to assess the outcome of Morton’s neuroma treatment using ultrasound guided radiofrequency ablation versus ultrasound guided ethanol ablation. The trial is conducted with Dr Renee Silvester of the University of Western Australia under supervision of Prof Alan Bryant and Dr Mark Hamlin.

Online Appointments

View available appointment times for computed
tomography (CT) and ultrasound and make a
secure online appointment.